{"id":15384,"date":"2019-08-14T09:29:47","date_gmt":"2019-08-14T09:29:47","guid":{"rendered":"https:\/\/www.bensnaturalhealth.com\/blog\/?p=15384"},"modified":"2026-07-29T10:30:14","modified_gmt":"2026-07-29T10:30:14","slug":"saw-palmetto-prostate","status":"publish","type":"post","link":"https:\/\/www.bensnaturalhealth.com\/blog\/prostate-health\/saw-palmetto-prostate\/","title":{"rendered":"Can Saw Palmetto Treat an Enlarged Prostate?"},"content":{"rendered":"Millions of men reach for saw palmetto hoping it’ll quiet a bladder that wakes them at 2 a.m. or fix that maddening weak stream. The honest answer, though? Probably not, at least not in any way the clinical evidence consistently backs up.<\/span>\n

Does Saw Palmetto Actually Help Enlarged Prostate?<\/b><\/h2>\nSaw palmetto (<\/span>Serenoa repens<\/span><\/i>) ranks among the most widely sold herbal supplements on the planet, driven mostly by its reputation for relieving benign prostatic hyperplasia, the non-cancerous<\/span> enlarged prostate<\/span><\/a> that affects roughly 50% to 75% of men over 50, climbing to about<\/span> 80% by age 70<\/span><\/a>. The global saw palmetto supplement market was estimated at $156.3 million in 2024, according to<\/span> Fact.MR<\/span><\/a>, with forecasts projecting growth toward $358.5 million by 2034 at an 8.7% compound annual growth rate per<\/span> Exactitude Consultancy<\/span><\/a>.<\/span>\n\nThat commercial momentum doesn’t track with the clinical evidence, though. Saw palmetto isn’t a cure for BPH. It can’t shrink prostate tissue the way prescription 5-alpha-reductase inhibitors do, and major clinical trials haven’t shown it outperforms a placebo for urinary symptoms. Getting familiar with your<\/span> prostate gland’s function<\/span><\/a> is a useful first step, once you understand what BPH actually does, it’s easier to judge what a supplement can and can’t realistically address.<\/span>\n\nMarket analysis from<\/span> Growth Market Reports<\/span><\/a>,<\/span> Future Market Insights<\/span><\/a>,<\/span> Market Research Intellect<\/span><\/a>,<\/span> Business Research Insights<\/span><\/a>,<\/span> Persistence Market Research<\/span><\/a>, and<\/span> The Market Intelligence<\/span><\/a> all point to strong consumer demand. But demand isn’t evidence.<\/span>\n

What the current research shows<\/b><\/h3>\nThe American Urological Association (AUA) and the National Institutes of Health (NIH\/NCCIH) both conclude that saw palmetto hasn’t demonstrated meaningful clinical benefit for BPH beyond placebo. Full stop. Harvard Medical School has reported the same, rigorous, well-designed trials simply haven’t confirmed the symptom relief that smaller, earlier studies suggested. Men taking saw palmetto don’t see statistically meaningful improvements in urinary flow rate or prostate size compared to men on a placebo. The evidence points pretty consistently in one direction.<\/span>\n\nThe question isn’t completely closed on the mechanistic side, though. And many men still try it, often for sensible reasons.<\/span>\n

Why men try it<\/b><\/h3>\nThe urinary symptoms of BPH are genuinely disruptive. A weak stream that makes bathroom trips drag on twice as long, constant daytime frequency, and<\/span> nocturia<\/span><\/a>, waking up multiple times a night, push men toward anything that promises relief without a prescription. Saw palmetto is widely available, relatively affordable, and carries a long history of traditional use; in several Western European countries it’s actually considered a first-line option. That combination makes it appealing, especially for men who want to sidestep the<\/span> sexual side effects tied to prescription medications<\/span><\/a> sometimes associated with erectile dysfunction and libido changes. These are patient motivations, though. They don’t reflect proven outcomes.<\/span>\n

How Saw Palmetto Is Supposed to Work<\/b><\/h2>\nThe proposed mechanisms behind saw palmetto are genuinely interesting. They just haven’t translated into confirmed human benefit yet. The leading theory involves 5-alpha-reductase inhibition, an enzyme that converts testosterone into dihydrotestosterone (DHT), a hormone driving prostate cell growth that, in laboratory settings, saw palmetto appears to partially block. Exercise influences<\/span> testosterone and DHT levels<\/span><\/a> in ways that may also bear on prostate health, though the clinical picture remains complex. For a fuller picture of<\/span> saw palmetto benefits and proposed mechanisms<\/span><\/a>, the story reaches well beyond BPH alone.<\/span>\n\nIt’s also worth comparing it directly with beta-sitosterol, another plant compound frequently studied for prostate support. A<\/span> comparison between beta-sitosterol and saw palmetto<\/span><\/a> reveals meaningful differences in the quality and direction of evidence for each.<\/span>\n

The proposed mechanisms<\/b><\/h3>\nSaw palmetto extract is thought to act through several pathways, all currently classified as proposed or preclinical:<\/span>\n